Tempus AI (NASDAQ:TEM) Trading 6.4% Higher – Here’s Why

Tempus AI, Inc. (NASDAQ:TEM) shot up 6.4% during mid-day trading on Tuesday . The company traded as high as $46.22 and last traded at $46.11. 589,929 shares were traded during mid-day trading, a decline of 47% from the average session volume of 1,121,543 shares. The stock had previously closed at $43.34.

Analysts Set New Price Targets

A number of research firms have issued reports on TEM. JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. William Blair assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set an “outperform” rating for the company. Piper Sandler assumed coverage on shares of Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 price target for the company. Morgan Stanley assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set an “overweight” rating and a $44.00 price target for the company. Finally, Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $48.67.

Tempus AI Price Performance

The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70. The business’s 50-day moving average is $51.47.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. Equities research analysts predict that Tempus AI, Inc. will post -6.51 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vestor Capital LLC bought a new position in Tempus AI during the third quarter worth $153,000. Sandia Investment Management LP bought a new position in Tempus AI during the second quarter worth $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Tempus AI during the third quarter worth $258,000. Clarus Group Inc. bought a new position in Tempus AI during the third quarter worth $283,000. Finally, Janney Capital Management LLC bought a new position in shares of Tempus AI in the third quarter valued at $385,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.